FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2559877690> ?p ?o ?g. }

• W2559877690 abstract "Abstract Patient relapse due to the emergence of imatinib-resistance in advanced chronic myelogenous and Ph+ acute lymphocytic leukemias has prompted the search for improved Bcr-Abl kinase inhibitors. Up to 40% imatinib-resistant patients express mutant forms of the Bcr-Abl kinase that reduce binding of imatinib without significantly decreasing kinase activity. However, some mutants are only partially resistant, since higher concentrations of imatinib may still block kinase activity and have a beneficial clinical effect. More potent Bcr-Abl inhibitors or inhibitors with different contact points with the kinase domain are predicted to be useful for the treatment of imatinib-resistant disease. Rational drug design based upon the crystal structure of an Abl-imatinib complex, together with medicinal chemistry paradigms, resulted in the discovery of AMN107. AMN107 is a low molecular weight compound that selectively inhibits the c-Abl/Bcr-Abl, imatinib-resistant mutants of Bcr-Abl, PDGFR, and c-Kit tyrosine kinases, with IC50 values for the inibition of autophosphorylation (cell capture ELISA) of 23 nM (32D cells transfected with p210 Bcr-Abl), 83 nM (A31 cells) and 192 nM (GIST cells), respectively. Following oral administration to mice (20 mg/kg in NMP-PEG300 10:90 v/v), AMN107 was well absorbed, with a mean plasma level after 2 h in the range of 6.0-12.1 M, which corresponds to >100-fold that required to inhibit Bcr-Abl autophosphorylation in 32D.p210 cells. Following injection of 32D.p210-luciferase cells into Balb/c mice, serial imaging of the leukemic clone in live mice indicated that AMN107 could substantially reduce the accumulation of leukemic cells in the marrow, nodes, liver, and spleen, compared to a vehicle control. Further, administration of AMN107 (75 mg/kg/day p.o.) to BALB/c mice over an 18 day period, commencing 3 days after the injection of 32 D.p210 cells, resulted in the protection of 15/20 animals over 100 days observation, whereas 19/20 vehicle treated animals developed a lethal leukemic disease(all deaths occurred within 36 days of cell injection). The spleen sizes of the surviving animals in the treated group were in the normal range (0.142±0.043 g; n = 17), whereas those of the vehicle treated animals were 0.50±0.045 (n = 20). These results were confirmed in a bone marrow transplant assay, where AMN107 was found to prolong survival of mice transplanted with marrow cells infected with a p210Bcr/Abl retrovirus. AMN107 also prolonged survival of mice transplanted with a Bcr/Abl mutant (E255V) associated with imatinib resistance in patients, while imatinib treatment was unsuccessful. These in vivo studies, along with in vitro studies reported separately, indicate that AMN107 is a highly active inhibitor of Bcr/Abl that may have clinical utility in patients with Bcr/Abl+ leukemias." @default.
• W2559877690 created "2016-12-16" @default.
• W2559877690 creator A5002832662 @default.
• W2559877690 creator A5011479527 @default.
• W2559877690 creator A5013829081 @default.
• W2559877690 creator A5027429869 @default.
• W2559877690 creator A5029251605 @default.
• W2559877690 creator A5039503690 @default.
• W2559877690 creator A5039714382 @default.
• W2559877690 creator A5046655874 @default.
• W2559877690 creator A5055853326 @default.
• W2559877690 creator A5077097430 @default.
• W2559877690 date "2004-11-16" @default.
• W2559877690 modified "2023-10-17" @default.
• W2559877690 title "AMD107: Efficacy as a Selective Inhibitor of the Tyrosine Kinase Activity of BCR-ABL in Murine Leukemia Models." @default.
• W2559877690 doi "https://doi.org/10.1182/blood.v104.11.551.551" @default.
• W2559877690 hasPublicationYear "2004" @default.
• W2559877690 type Work @default.
• W2559877690 sameAs 2559877690 @default.
• W2559877690 citedByCount "2" @default.
• W2559877690 crossrefType "journal-article" @default.
• W2559877690 hasAuthorship W2559877690A5002832662 @default.
• W2559877690 hasAuthorship W2559877690A5011479527 @default.
• W2559877690 hasAuthorship W2559877690A5013829081 @default.
• W2559877690 hasAuthorship W2559877690A5027429869 @default.
• W2559877690 hasAuthorship W2559877690A5029251605 @default.
• W2559877690 hasAuthorship W2559877690A5039503690 @default.
• W2559877690 hasAuthorship W2559877690A5039714382 @default.
• W2559877690 hasAuthorship W2559877690A5046655874 @default.
• W2559877690 hasAuthorship W2559877690A5055853326 @default.
• W2559877690 hasAuthorship W2559877690A5077097430 @default.
• W2559877690 hasConcept C104317684 @default.
• W2559877690 hasConcept C121608353 @default.
• W2559877690 hasConcept C125418893 @default.
• W2559877690 hasConcept C126322002 @default.
• W2559877690 hasConcept C143065580 @default.
• W2559877690 hasConcept C150109051 @default.
• W2559877690 hasConcept C170493617 @default.
• W2559877690 hasConcept C184235292 @default.
• W2559877690 hasConcept C185592680 @default.
• W2559877690 hasConcept C203014093 @default.
• W2559877690 hasConcept C2776960273 @default.
• W2559877690 hasConcept C2777413986 @default.
• W2559877690 hasConcept C2777583451 @default.
• W2559877690 hasConcept C2778461978 @default.
• W2559877690 hasConcept C2778729363 @default.
• W2559877690 hasConcept C2778820342 @default.
• W2559877690 hasConcept C2779536868 @default.
• W2559877690 hasConcept C3019892230 @default.
• W2559877690 hasConcept C32619005 @default.
• W2559877690 hasConcept C42362537 @default.
• W2559877690 hasConcept C43907098 @default.
• W2559877690 hasConcept C502942594 @default.
• W2559877690 hasConcept C552990157 @default.
• W2559877690 hasConcept C55493867 @default.
• W2559877690 hasConcept C62478195 @default.
• W2559877690 hasConcept C71924100 @default.
• W2559877690 hasConcept C81089528 @default.
• W2559877690 hasConcept C97029542 @default.
• W2559877690 hasConcept C98274493 @default.
• W2559877690 hasConceptScore W2559877690C104317684 @default.
• W2559877690 hasConceptScore W2559877690C121608353 @default.
• W2559877690 hasConceptScore W2559877690C125418893 @default.
• W2559877690 hasConceptScore W2559877690C126322002 @default.
• W2559877690 hasConceptScore W2559877690C143065580 @default.
• W2559877690 hasConceptScore W2559877690C150109051 @default.
• W2559877690 hasConceptScore W2559877690C170493617 @default.
• W2559877690 hasConceptScore W2559877690C184235292 @default.
• W2559877690 hasConceptScore W2559877690C185592680 @default.
• W2559877690 hasConceptScore W2559877690C203014093 @default.
• W2559877690 hasConceptScore W2559877690C2776960273 @default.
• W2559877690 hasConceptScore W2559877690C2777413986 @default.
• W2559877690 hasConceptScore W2559877690C2777583451 @default.
• W2559877690 hasConceptScore W2559877690C2778461978 @default.
• W2559877690 hasConceptScore W2559877690C2778729363 @default.
• W2559877690 hasConceptScore W2559877690C2778820342 @default.
• W2559877690 hasConceptScore W2559877690C2779536868 @default.
• W2559877690 hasConceptScore W2559877690C3019892230 @default.
• W2559877690 hasConceptScore W2559877690C32619005 @default.
• W2559877690 hasConceptScore W2559877690C42362537 @default.
• W2559877690 hasConceptScore W2559877690C43907098 @default.
• W2559877690 hasConceptScore W2559877690C502942594 @default.
• W2559877690 hasConceptScore W2559877690C552990157 @default.
• W2559877690 hasConceptScore W2559877690C55493867 @default.
• W2559877690 hasConceptScore W2559877690C62478195 @default.
• W2559877690 hasConceptScore W2559877690C71924100 @default.
• W2559877690 hasConceptScore W2559877690C81089528 @default.
• W2559877690 hasConceptScore W2559877690C97029542 @default.
• W2559877690 hasConceptScore W2559877690C98274493 @default.
• W2559877690 hasLocation W25598776901 @default.
• W2559877690 hasOpenAccess W2559877690 @default.
• W2559877690 hasPrimaryLocation W25598776901 @default.
• W2559877690 hasRelatedWork W1519449155 @default.
• W2559877690 hasRelatedWork W1978777017 @default.
• W2559877690 hasRelatedWork W2013963600 @default.
• W2559877690 hasRelatedWork W2070299475 @default.
• W2559877690 hasRelatedWork W2093585213 @default.
• W2559877690 hasRelatedWork W2100041900 @default.
• W2559877690 hasRelatedWork W2122367401 @default.
• W2559877690 hasRelatedWork W2553742303 @default.

• next